Quality of life in ovarian cancer patients choosing to receive salvage chemotherapy or palliative treatment

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 12, 2013, Pages 7669-7674

  Srisuttayasathien, Manasawee ^a   Khemapech, Nipon ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Ovarian cancer; Palliative care; Quality of life; Salvage chemotherapy

Indexed keywords

ANTINEOPLASTIC AGENT;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER GRADING; CANCER STAGING; COLLOID CARCINOMA; CYSTADENOCARCINOMA; ENDOMETRIUM TUMOR; FEMALE; FOLLOW UP; HUMAN; MIDDLE AGED; OVARY TUMOR; PALLIATIVE THERAPY; PATHOLOGY; PROGNOSIS; QUALITY OF LIFE; QUESTIONNAIRE; SALVAGE THERAPY; SURVIVAL RATE; THAILAND; TUMOR RECURRENCE; YOUNG ADULT;

ADENOCARCINOMA, CLEAR CELL; ADENOCARCINOMA, MUCINOUS; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYSTADENOCARCINOMA, SEROUS; ENDOMETRIAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; OVARIAN NEOPLASMS; PALLIATIVE CARE; PROGNOSIS; QUALITY OF LIFE; QUESTIONNAIRES; SALVAGE THERAPY; SURVIVAL RATE; THAILAND; YOUNG ADULT;

EID: 84893428268     PISSN: 15137368     EISSN: None     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.12.7669     Document Type: Article

References (23)

1. Beesley VL, Green AC, Wyld DK, et al (2013). Quality of life and treatment response among woman with platinumresistant versus platinum-sensitive ovarian cancer treated for progression: A prospective analysis. Gynecol Oncol, [Epub ahead of print].
2. Berek JS, Jonathan S (2011). Berek and Novak's Gynecology. Philadelphia, USA.
3. Bodurka-Bevers D, Basen-Engquist K, Carmack CL, et al (2000). Depression, anxiety, and quality of life in patients with epithelial ovarian cancer. Gynecol oncol, 78, 302-8.
4. Carter JR, Chen MD, Fowler JM, et al (1997). The effect of prolonged cycle of chemotherapy on quality of life in gynecologic cancer patients. J Obstet Gyneacol Res, 23, 197-203.
5. Cheng KK, Yeung MM (2013). Symptom distress in older adults during cancer therapy: impact on performance status and quality of life. J Geriatr Oncol, 4, 71-7.
6. Doyle C, Crump M, Pintilie M, et al (2001). Does Palliative Chemotherapy Palliate? Evaluation of expectations, outcomes, and costs in woman receiving chemotherapy for advanced ovarian cancer. J Clin Oncol, 19, 1266-74.
7. Gordon AN, Tonda M, Sun S, et al (2004). Long-term survival advantage for women treated with pegylated liposomal doxorubicin compared with topotecan in a phase 3 randomized study of recurrent and refractory epithelial ovarian cancer. Gynecol Oncol, 95, 1-8.
8. Greimel E, Thiel I, PeintingerF, et al (2002). Prospective assessment of quality of life of female cancer patients. Gynecol Oncol, 85, 140-7.
9. Grzankowski KS, Carney M (2011). Quality of life in ovarian cancer. Cancer Control, 18, 52-8.
10. Hamilton AB (1999). Psychological aspects of ovarian cancer. Cancer Invest, 17, 335-41.
11. Lakusta CM, Atkinson MJ, Robinson JW, et al (2001). Quality of life in ovarian cancer patients receiving chemotherapy. Gynecol Oncol, 81, 490-5.
12. Roland KB, Rodriguez JL, Patterson JR, et al (2013). A literature review of social and psychological needs of ovarian cancer survivors. Psychooncology, 22, 2408-18.
13. Macquart-Moulin G VP, Palangié T, Bouscary ML, et al (2000). High-dose sequential chemotherapy with recombinant granulocyte colony-stimulating factor and repeated stem-cell support for inflammatory breast cancer patients: does impact on quality of life jeopardize feasibility and acceptability of treatment? J Clin Oncol, 18, 754-64.
14. Mishra K (2011). Gynaecological malignancies from palliative care perspective. Indian J Palliat Care, 17, 45-51.
15. National Comprehensive Cancer Network (2013). Epithelial ovarian cancer/fallopian tube cancer/primary peritoneal cancer.
16. Patnaik A, Doyle C, Oza AM (1998). Palliative therapy in advanced ovarian cancer: balancing patient expectations, quality of life and cost. Anti-Cancer Drug, 9, 869-78.
17. Peterman AH, Rothrock N, Cella D (2012). Evaluation of health-related quality of life. In: UpToDate, Basow, DS(Ed), UpToDate, Waltham, MA.
18. Price MA, Bell ML, Friedlander M, et al (2013). Physical symptoms, coping styles and quality of life in recurrent ovarian cancer: A prospective population-based study over the last year of life. Gynecol Oncol, 130, 162-8.
19. Sfakianos GP, Havrilesky LJ (2011). A review of costeffectiveness studies in ovarian cancer. Cancer Control, 18, 59-64.
20. Sun CC, Ramirez PT, Bodurka DC (2007). Quality of life for patients with epithelial ovarian cancer. Nat Clin Pract Oncol, 4, 18-29.
21. Von Gruenigen VE, Huang HQ, Gil KM, et al (2010). A comparison of quality-of-life domains and clinical factors in ovarian cancer patients: A Gynecologic Oncology Group study. J Pain Symptom Manage, 39, 839-46.
22. Wang Y, Shen J, Xu Yan (2011) Symptoms and quality of life of advanced cancer patients at home: a cross-sectional study in Shanghai, China. Support Care Cancer, 19, 789-97.
23. Wilailak S, Lertkhachonsuk A, Lohacharoenvanich N, et al (2011). Quality of life in gynecologic cancer survivors compared to healthy check-up woman. J Gynecol Oncol, 22, 103-9.